FENC Operating Income Growth
Fennec Pharmaceuticals Inc · Operating Income Growth
FENC Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported88.05%period ending
FENC TTM Operating Income YoY % (-26.28% → 88.05%)
Year-over-year change
High-resolution chart · PNG
FENC operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 88.0534% | |
| 53.2304% | |
| -351.1499% | |
| -383.4035% | |
| -265.8715% | |
| -292.9189% | |
| 119.7479% | |
| 109.732% | |
| 124.4848% | |
| 125.6735% | |
| 43.4636% | |
| 17.2935% | |
| -41.5412% | |
| -53.433% | |
| -31.156% | |
| -26.2743% | |
| 6.1669% | |
| 16.4813% | |
| 3.7014% | |
| 10.0594% | |
| -27.1344% | |
| -33.9523% | |
| -37.4817% | |
| -45.9915% | |
| -5.5779% | |
| -25.3673% | |
| -24.9784% | |
| -26.907% | |
| -46.8385% | |
| -41.7388% | |
| -49.7482% | |
| -75.9047% | |
| -131.2374% | |
| -150.0314% | |
| -142.1108% | |
| -145.2548% | |
| -93.1707% | |
| -68.4989% | |
| -51.9048% | |
| -6.8545% | |
| 14.973% | |
| 32.235% | |
| 34.3066% | |
| 14.8681% | |
| -24.6639% | |
| -44.5883% | |
| -48.9902% | |
| 5.1554% | |
| 39.8819% | |
| 45.452% | |
| 46.6427% | |
| 22.3661% | |
| 13.3351% | |
| -87.3016% | |
| -57.6906% | |
| -53.8253% | |
| -70.1192% | |
| 64.0616% | |
| 50.152% | |
| 41.109% | |
| 24.9656% | |
| -285.5572% | |
| -56.0678% | |
| 33.3393% | |
| 67.1487% | |
| 88.0372% | |
| 78.7556% | |
| 60.994% | |
| 39.2992% | |
| 21.4251% | |
| 2.1424% | |
| 11.9619% | |
| 17.6059% | |
| 20.4401% | |
| 18.5937% | |
| 4.9734% | |
| -2.4524% | |
| -0.0135% | |
| 4.99% | |
| -293.0713% | |
| -529.5227% | |
| -2,471.9278% | |
| -7,806,957.8723% | |
| 59.8695% | |
| 70.8411% | |
| 91.9903% | |
| 99.9971% | |
| -54.8208% | |
| -43.273% | |
| -54.9057% | |
| -70.2543% | |
| -66.4122% | |
| -62.1627% | |
| -9.7523% | |
| -9.9447% | |
| -1.9704% | |
| -26.2827% |